title: Hinge peptide combinatorial libraries for inhilbitors of botulinum neurotoxins and saxitoxin: deconvolution strategy.
abstract: Abstract Combinatorial library screening offers a rapid process for identifying potential therapies to toxins. Hinge peptide libraries, which rely on conformational diversity rather than traditional molecular diversity, reduce the need for huge numbers of syntheses and screening steps and greatly expedite the discovery process of active molecules. Hinge peptide libraries having the structures: Acetyl-X1-X2-hinge-X3-X4-NH2 (capped) and X1-hinge-X2-X3 (uncapped), where X1 through X4 are near-equimolar mixtures of twelve L-amino acids and hinge = 4-aminobutyric acid, were screened for inhibitory activity in bioassays for botulinum neurotoxins A and B (BoNT/A, BoNT/B) and saxitoxin. The zinc protease activity of the reduced light chains of BoNT/A and /B was assayed by measuring the cleavage of synthetic substrates. Saxitoxin activity was measured by the restoration of the viability of neuroblastoma cells treated with ouabain and veratridine. Deconvolution of libraries was accomplished by fixing one position at a time beginning with the C-terminus. Primary library subsets in which position 4 was fixed showed moderate levels of inhibition for BoNT/A. Secondary library subsets showed stronger inhibition in the bioassays. In each of the bioassays, inhibitory potency was stronger when the second position to be fixed was on the opposite side of the hinge, rather than on the same side with respect to the C-terminus, suggesting that the hinge facilitates the interaction of side chains. Inhibitors for all three of the toxins studied were discovered within library subsets, although not necessarily in primary subsets. These studies demonstrate that (1) the best strategy for deconvoluting hinge peptide libraries is by fixing residues alternately on each side of the hinge moiety, and (2) it is essential to investigate secondary subsets even when primary subsets are inactive. The present findings support the concept that the increased flexibility imposed by the inclusion of a central hinge residue in small peptides increases the opportunity for side chain interactions, providing a distinct advantage for hinge peptide libraries over conventional peptide libraries. Hinge peptide libraries are a rich source of novel ligands for modulation of biomechanisms. The library subsets uncovered in this study may possess peptides that will lead to effective therapies to neurotoxin poisoning.
authors.affiliation: PepMetics Inc., 772 Murphy Place, Victoria, British Columbia, Canada V8Y 3H4.
authors.forename: Graham J
authors.initials: GJ
authors.lastname: Moore
authors.forename: Diana M
authors.initials: DM
authors.lastname: Moore
authors.forename: Samir S
authors.initials: SS
authors.lastname: Roy
authors.forename: Lawrence J
authors.initials: LJ
authors.lastname: Hayden
authors.forename: Murray G
authors.initials: MG
authors.lastname: Hamilton
authors.forename: Nora W C
authors.initials: NW
authors.lastname: Chan
authors.forename: William E
authors.initials: WE
authors.lastname: Lee
mesh_terms: D001681:Biological Assay; D001905:Botulinum Toxins / Q000037:antagonists & inhibitors* / Q000737:chemistry; D019274:Botulinum Toxins, Type A / Q000037:antagonists & inhibitors* / Q000737:chemistry; D002470:Cell Survival / Q000187:drug effects; D020650:Combinatorial Chemistry Techniques; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D008024:Ligands; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors / Q000378:metabolism; D009447:Neuroblastoma / Q000378:metabolism / Q000473:pathology; D010042:Ouabain / Q000494:pharmacology; D010446:Peptide Fragments / Q000737:chemistry* / Q000378:metabolism; D019151:Peptide Library; D011480:Protease Inhibitors / Q000494:pharmacology; D012530:Saxitoxin / Q000037:antagonists & inhibitors* / Q000737:chemistry; D014701:Veratridine / Q000494:pharmacology; D015032:Zinc / Q000737:chemistry
chemical_list: D004791:Enzyme Inhibitors; D008024:Ligands; D010446:Peptide Fragments; D019151:Peptide Library; D011480:Protease Inhibitors; C096323:rimabotulinumtoxinB; D012530:Saxitoxin; D010042:Ouabain; D014701:Veratridine; D008666:Metalloendopeptidases; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A; D015032:Zinc